Bullish Case: TRU is down 27% in a month, oversold at $61.13 with P/B at 5.0 versus a two-year base near $103. Helium's price density peaks near $65 — above spot — and front-month Helium IV (~35.8) sits below the market's ~47, implying the market is overpricing continued panic. VantageScore 4.0's $0.99 pricing extension through 2028 lets TRU monetize the GSE adoption channel, and mean reversion has repeatedly followed prior regulatory headline dips.

Bearish Case: FHFA's Pulte has called the bureaus 'cartel-like,' is reviving bi-merge/single-report studies, and instructed the GSEs to accept VantageScore — directly threatening tri-merge revenue. Put volume ran 2,587% of calls and bearish risk exceeds bullish risk by 9% across tenors; deep-put IV (45-strike ~56.6%) confirms live jump risk. CDIA estimates single-report could hurt scores for 27.8M consumers — structural, not just sentiment, damage.

Potential Outcomes:

1. 40% Partial stabilization $58–$66: headline noise fades, Helium density peak at $65 holds; falsified if put-IV expands further.
2. 25% Continued regulatory slide to $52–$57 as bi-merge/single-report advances; verify via expanding 50-strike put IV.
3. 20% Relief rally to $68–$73 if FHFA softens or implementation timelines stretch into 2027+.
4. 10% Rangebound $60–$64 with IV compression post-Oct-17 expiry.
5. 5% Tail <$50 on formal bi-merge rule or enforcement action; deep-put skew already implies this jump risk.

October 01, 2026